Personalised Breast Cancer Screening
Work package 2
Breast density patterns and the change of these patterns between consecutive screening exams are very powerful risk factors as well. SME Biomediq will take the lead in the development of meaningful density pattern measures. Synergies between Biomediq, Mātakina and the research partners will be exploited.